Cambrian Capital Partners
Cambrian Capital Partners is a private equity firm established in 2019 and based in Edmonton, Canada. The firm specializes in offering off-market and creative investment solutions, primarily targeting lower mid-market companies. Cambrian Capital Partners focuses its investments in the building materials, agriculture, and agricultural technology sectors, seeking to identify opportunities that align with its strategic vision.
2 past transactions
CND Life Sciences
Series A in 2025
CND Life Sciences develops an evidence-based tool for confirming synucleinopathy diagnoses. Its Syn-One Test detects abnormal alpha-synuclein in cutaneous nerve fibers, aiding in diagnosing Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure.
CND Life Sciences
Seed Round in 2022
CND Life Sciences develops an evidence-based tool for confirming synucleinopathy diagnoses. Its Syn-One Test detects abnormal alpha-synuclein in cutaneous nerve fibers, aiding in diagnosing Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.